Always seek the guidance of your healthcare provider for any questions regarding your health or medical conditions
1,3 A 2025 systematic review in the International Journal of Dermatology confirmed that among GLP-1 receptor agonists, semaglutide and tirzepatide showed the highest reported incidence of hair loss, with telogen effluvium and androgenetic alopecia (AGA) identified as the predominant subtypes
Jensen SB, Sauerberg P, Nielsen FS, Pedersen BL, Skibsted E
How much weight can you lose on GLP-1 medications
Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review
The eligibility criteria of the Novo Nordisk Patient Assistant Program (PAP) in 2025: You must have a valid prescription from a certified healthcare professional for an FDA-approved indication